Abstract Although the lipid mediator sphingosine 1-phosphate (S1P) has been identified to induce cell growth arrest of human keratinocytes, the sphingolipid effectively protects these epidermal cells from apoptosis. The molecular mechanism of the anti-apoptotic action induced by S1P is less characterized. Apart from S1P, endogenously produced nitric oxide (NO • ) has been recognized as a potent modulator of apoptosis in keratinocytes. Therefore, it was of great interest to elucidate whether S1P protects human keratinocytes via a NO
Abstract Although the lipid mediator sphingosine 1-phosphate (S1P) has been identified to induce cell growth arrest of human keratinocytes, the sphingolipid effectively protects these epidermal cells from apoptosis. The molecular mechanism of the anti-apoptotic action induced by S1P is less characterized. Apart from S1P, endogenously produced nitric oxide (NO • ) has been recognized as a potent modulator of apoptosis in keratinocytes. Therefore, it was of great interest to elucidate whether S1P protects human keratinocytes via a NO
• -dependent signalling pathway. Indeed, S1P induced an activation of endothelial nitric oxide synthase (eNOS) in human keratinocytes leading to an enhanced formation of NO
• . Most interestingly, the cell protective effect of S1P was almost completely abolished in the presence of the eNOS inhibitor L-NAME as well as in eNOS-deficient keratinocytes indicating that the sphingolipid metabolite S1P protects human keratinocytes from apoptosis via eNOS activation and subsequent production of protective amounts of NO
•
. It is well established that most of the known actions of S1P are mediated by a family of five specific G protein-coupled
Introduction
Sphingolipids have long been viewed as important structural molecules of the epidermis, which are essential to secure the epidermal permeability barrier [1] . However, in the last years it has become evident that several types of sphingolipids such as ceramides, sphingosine, sphingosylphosphorylcholine, and sphingosine 1-phosphate (S1P) mediate a variety of cellular actions in epidermal cells [2] [3] [4] [5] . Thus, ceramides represent 30-40 % of stratum corneum lipids and its dysregulation is connected with skin disorders like atopic eczema [1] . Moreover, intracellular accumulation of ceramides has been indicated to inhibit keratinocyte growth and to induce apoptosis [6, 7] . Most interestingly, ceramides can be further metabolized to S1P, which is a versatile molecule involved in many regulatory processes of epidermal cells. Although S1P is a potent mitogen in a variety of cells such as fibroblasts, an opposed effect is visible in human keratinocytes [8, 9] . In analogy to ceramides, S1P inhibits proliferation of the epidermal cells and induces their differentiation [9] . It is of interest that despite the induction of growth arrest and in contrast to the action of ceramides, S1P does not drive keratinocytes into programmed cell death. Astonishingly, S1P effectively protects epidermal cells from apoptosis [10] . It has been suggested that S1P acts as a dual messenger, as an extracellular ligand for cell surface receptors, and as an intracellular signalling molecule, which induces distinct intracellular signalling pathways leading to a variety of physiological actions [11] . To date five members of the S1P receptor family have been identified, namely S1P 1-5 [12] , which are all present in human keratinocytes [8] . Intracellulary, S1P serves as a cofactor for tumor necrosis factor-a (TNFa) receptor-associated factor-2 (TRAF2), which is involved in nuclear factor kappa-B (NF k B) activation [13] . Moreover, intracellular S1P is involved in epigenetic transcriptional regulation as an inhibitor for the class I histone deacetylases HDAC1 and HDAC2 in the nucleus [14] . Nevertheless, the signalling mechanisms by which S1P evokes its anti-apoptotic action remain to be fully elucidated. It has been suggested that both intracellular and receptor-mediated actions play an essential role in the protective effect of S1P [15] [16] [17] .
Apart from the sphingolipid S1P, endogenously produced nitric oxide (NO • ) has been recognized as an important modulator of skin homeostasis orchestrating a wide range of physiological and pathophysiological processes including keratinocyte proliferation, differentiation, and apoptosis [18, 19] . NO
• is produced from L-arginine and oxygen in a two-step oxidation via NO
• -synthases (NOS) [20, 21] . The family of NOS consists of three main isoforms, including neuronal NOS (nNOS, NOS1), endothelial NOS (eNOS, NOS3), and inducible NOS (iNOS, NOS2), which differ not only in cellular localization but also in activation and kinetics [22, 23] . Both, the calcium-dependent nNOS and the eNOS, synthesize low levels of NO
• generally for homeostatic effects. It has been indicated that both isoforms are involved in epidermal permeability barrier recovery after disruption [24, 25] . In contrast to the constituent isoforms, iNOS generates much higher levels of NO • . Consequently, it is not astonishing that iNOS plays a critical role in immune defense, and moreover is increased in pathological skin estates [26] [27] [28] . Hence, iNOS expression is under the transcriptional control of proinflammatory molecules such as NF-jB or Jun/Fos heterodimers [29] . NO • possesses a bimodal action regarding the survival of keratinocytes. Indeed, NO
• can either induce or suppress apoptosis mainly depending on the NO
• concentration and the corresponding activation of the specific NOS isoform [30, 31] . In addition, it has been observed that in eNOSdeficient mice, the epidermal apoptotic rate significantly increased in response to UV exposure suggesting a protective action of eNOS in human keratinocytes [19] . It has been shown that eNOS can be activated by a variety of stimuli, which lead to an increased cytoplasmatic Ca 2? level followed by the association of Ca 2? /calmodulin with eNOS [32] . In addition, phosphorylation of eNOS at Ser 1177 via several signal transduction pathways promotes eNOS activation. Besides a phosphorylation of eNOS via phosphoinositide-3 kinase (PI3K)/Akt, an involvement of protein kinase A (PKA), AMP-activated kinase, and Ca 2? /calmodulin-dependent kinase-II have been discussed as crucial events in eNOS activation [33, 34] . The mechanism of the protective action of eNOS still remains uncertain. An induction of B cell lymphoma-2 protein (Bcl-2) expression and inhibition of caspase activation have been figured out. These effects may be a result of either a direct S-nitrosylation or a consequence of NO
• -mediated activation of soluble guanylate cyclase and consequent cyclic guanosine monophosphate formation [31] .
As both, S1P and NO • formation via eNOS, protect human keratinocytes from apoptosis, it was of great interest to investigate an interference of both signalling pathways. Indeed, our findings clearly indicate that the anti-apoptotic action of S1P is mediated via NO
• formation through eNOS activation. Moreover, we identified the S1P 3 as the crucial receptor subtype responsible for eNOS activation as well as cytoprotection in human keratinocytes.
Materials and methods

Materials
S1P was synthesized as recently described [35] . S1P was dissolved in methanol and stored at -80°C. For each experiment, stored S1P was dried and freshly diluted in 0.4 % fatty acid free bovine serum albumin (BSA)/phosphate-buffered saline (PBS). Annexin V-fluorescein isothiocyanate (Annexin V-FITC) was obtained from Enzo Life Sciences (Lörrach, Germany). Fetal bovine serum (FBS), collagen A 1, and Optimem were obtained from Biochrom (Berlin, Germany). Keratinocyte basal medium (KBM), epidermal growth factor, insulin, hydrocortisone, bovine pituitary extract, gentamycin sulfate, and amphotericin B were purchased from Lonza (Verviers, Belgium). Polyclonal rabbit anti-phospho-eNOS (Ser 1177 )-antibody, anti-rabbit IgG, anti-mouse IgG, sodium dodecyl sulfate (SDS) sample buffer, dithiothreitol, LumiGlo Ò reagent, and peroxide were obtained from New England Biolabs (Beverly, MA). Purified mouse anti-eNOS antibody was purchased from Becton-Dickinson (Heidelberg, Germany). The secondary ape Cy2-linked anti-mouse-antibody was ordered from Jackson Immuno Research Laboratories (Newmarket, UK). Polyvinylidene difluoride (PVDF) membranes were obtained from Millipore (Schwalbach, Germany). Primers were synthesized by TIB Molbiol (Berlin, Germany). NTER Ó Transfection System, small interfering ribonucleic acid (siRNA) against S1P 3 and eNOS, control siRNA, Fluoromount
, tumor necrosis factor a (TNFa), propidium iodide (PI), 4 0 ,6-diamidino-2-phenylindole (DAPI), pertussis toxin (PTX), fatty acid free BSA, trypsin, PBS, Ipegal, sodium deoxycholate, SDS, phenylmethylsulfonyl fluoride (PMSF), leupeptin, aprotinin, pepstatin, ethylenediamine tetraacetic acid (EDTA), HEPES, Dulbecco's Modified Eagle's Medium (DMEM), penicillin/streptomycin, and all other chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany).
Keratinocyte culture
Human keratinocytes were isolated from juvenile foreskin from surgery as described [9] . In brief, the skin was incubated at 4°C in a solution of 0.25 % trypsin and 0.2 % EDTA for 20 h. Trypsinization was terminated by addition of ice-cold DMEM containing 10 % FBS. Keratinocytes were relieved from the epidermis by gently pivoting, washed with PBS, and centrifuged at 2509g for 5 min. After washing the cells with PBS, the pellet was resuspended in keratinocyte growth medium (KGM), which was prepared from KBM by the addition of 0.1 ng/ml epidermal growth factor, 5.0 lg/ml insulin, 0.5 lg/ml hydrocortisone, 0.15 mM Ca 2? , 30 lg/ml bovine pituitary extract, 50 lg/ml gentamycin sulfate, and 50 ng/ml amphotericin B. Keratinocytes were pooled from several donors and cultured at 37°C in 5 % CO 2 . For all experiments only cells of the 2nd and 3rd passage were used.
Measurement of apoptosis by flow cytometry
Keratinocytes were seeded in six-well plate (8 9 10 4 cells per well) and cultured for 24 h in KGM. Apoptosis was induced by incubation with 20 ng/ml TNFa for 16 h. Then cells were trypsinized and washed twice with binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ). Apoptosis was determined by flow cytometric detection (FACS Canto II, Becton-Dickinson, Heidelberg, Germany) of phosphatidylserine translocation using FITC-labelled Annexin V. To discriminate between early apoptotic cells (Annexin V ? /PI -) as well as late apoptotic cells (Annexin V ? /PI ? ), dye exclusion of the nonvital dye PI was simultaneously measured. Therefore, cells were resuspended in binding buffer followed by the addition of Annexin V-FITC (final concentration 0.5 lg/ml). The mixture was incubated for 10 min in the dark at room temperature. Then, PI was added (1 lg/ml) and samples were analyzed by bivariate flow cytometry as described [10] . The determined apoptotic rates in percent represent Annexin V ? /PI -and Annexin V ? /PI ? keratinocytes.
Quantitative real-time PCR Keratinocytes were cultured in KGM and RNA was collected using an RNeasy kit (Qiagen, Foster City, CA) and purified by DNA digestion with DNase I (Fermentas GmbH, St. Leon-Rot, Germany). cDNA was generated from total RNA using the FermentasAid TM First strand cDNA synthesis kit (Fermentas GmbH, St. Leon-Rot, Germany) according to the instructions of the manufacturer. Quantitative real-time PCR was performed using a LightCycler480 and the SYBR Green PCR master mix (Roche Diagnostics, Applied Science, Mannheim, Germany). CyclophilinA was used as normalization controls for all experiments. The following primers were used:
0 (reverse). Total RNA (10 ng) of three different sets of keratinocytes were used to analyze gene expression. Relative mRNA expression was quantified using the comparative threshold cycle method. Data were obtained in triplicate and the specific mRNA levels were expressed as the mean ± SEM of relative mRNA expression relative to control cells.
Western blot analysis
Keratinocytes were seeded in six-well plate (1.2 9 10 5 cells per well) and cultured for 24 h in KGM followed by a stimulation with the indicated substances. Cells were rinsed twice with ice-cold PBS and harvested in lysis buffer (PBS, 1 % Ipegal, 0.5 % sodium-deoxycholate, 0.1 % SDS) containing protease inhibitors (1 mM PMSF, 1 lg/ml leupeptin, 1 lg/ml aprotinin, 1 lg/ml pepstatin) and phosphatase inhibitors (1 mM sodium orthovanadate and 50 mM sodium fluoride). Lysates were centrifuged at 14,0009g for 30 min. Samples containing 20-40 lg protein were boiled in SDS sample buffer (100 mM Tris/HCl, pH 6.8, 4 % SDS, 0.2 % bromophenol blue, 20 % glycerol, 200 mM dithiothreitol) and separated by 7.5 % SDS polyacrylamide gel electrophoresis. Gels were semi-dry blotted onto PVDF membranes. After blocking with 5 % non-fat dry milk for 1 h at 37°C, membranes were incubated with the appropriate primary antibodies for 2 h at room temperature, and further incubated with horseradish-peroxidase-conjugated secondary antibodies for 1 h. Bound antibodies were detected by chemiluminescence using the ChemiDoc Nitrite determination NO
• production was measured indirectly by measuring the nitrite (NO 2 -) accumulation in the culture media using a spectrophotometric method based on Griess reaction. This assay relies on a diazotization reaction among NO 2 -, sulfanilamide, and NED under acidic conditions. For the measurement of NO 2 -release into the culture medium, confluent keratinocytes (5 9 10 4 cells/plate) were cultured in KGM and stimulated for the indicated time periods and concentrations. Then, 50 ll of cultured media were collected followed by the addition of 50 ll of Griess reagent. Finally, absorbance was determined at 540 nm using a multiplate reader FLUOstar OPTIMA Ò (BMG, Offenburg, Germany) after 10 min incubation at room temperature. The Griess reagent was composed of 0.1 % NED in distilled water and 1 % sulfanilamide in 5 % H 3 PO 4 .
NO
• visualization
Intracellular NO
• formation was detected using the cell permeable fluorescent dye DAF2-DA. Keratinocytes were seeded on a cover slip (1.5 9 10 4 cells) and grown in KGM in a sixwell plate for 24 h. After stimulation, cells were stained with 10 lM DAF2-DA for 30 min at 37°C. For staining of nuclei cells were treated with 1 lg/ml DAPI for 10 min. Cover slips were washed with PBS and cells were embedded in Fluoromount Ò . The highly fluorescent triazole derivative was analyzed by fluorescence microscopy using the Keyence BZ-9000 (Neu-Isenburg, Germany). Appropriate emission filter settings and controls were included for bleed-through effects.
Abrogation of eNOS and S1P 3 by siRNA Gene silencing was performed using target-specific eNOSand S1P 3 -siRNAs. Keratinocytes (5 9 10 4 cells/plate) were transfected with a final concentration of 50 nM eNOS-, S1P 3 -, or control-siRNAs in medium without antibiotics using the NTER Ò Transfection System according to the manufacturer's protocol. After a transfection period of 24 h, cells were incubated with KBM for 24 h. Then, keratinocytes were stimulated as indicated. The silencing efficiency of S1P 3 and eNOS were verified by quantitative real-time PCR.
Immunofluorescence microscopy of eNOS
Transfected keratinocytes were stimulated as described. Then, cells were washed with PBS and fixed in 1 % paraformaldehyde solution for 10 min. Afterwards cells were treated with blocking buffer (1 % BSA in PBS) for 20 min followed by the incubation with murine anti-eNOS antibodies (1:25 diluted in blocking buffer) for 60 min. Cells were washed three times with blocking buffer and incubated with Cy2-linked anti-mouse antibodies (1:125 diluted in blocking buffer). After 60 min, cells were washed three times with blocking buffer and incubated with DAPI (1 lg/ml) to stain the nuclei. Cells were embedded in Fluoromount Ò . Staining was examined using the Keyence BZ-9000 (Neu-Isenburg, Germany). Appropriate emission filter settings and controls were included for bleed-through effects.
Statistical analysis
Data are expressed as the mean ± SEM of results from at least three experiments, each run in triplicate. Statistics were performed using Student's t test. *P \ 0.05 and **P \ 0.01 indicate a statistically significant difference versus control experiments.
Results
S1P induces NO
• formation in human keratinocytes It has been indicated that both molecules, the sphingolipid S1P and the biological mediator NO • , possess protective effects on toxic insults-induced apoptosis in keratinocytes [10, 36] . However, it has not been identified whether a molecular cross-communication exists between both bioactive molecules in this epithelial cell type. Therefore, we measured not only the ability of S1P and NO
• to inhibit TNFa-induced apoptosis but also the influence of S1P to modulate NO
• formation in human keratinocytes. As expected, S1P significantly prevented keratinocytes from apoptosis induced by TNFa in a concentration-dependent manner. The ability of S1P to protect human keratinocytes from apoptosis became obvious after treatment with 0.1 lM of S1P, whereas maximal effects were measured with 5 lM of S1P (Fig. 1a) . In analogy, the NO • -donor SNAP also diminished TNFa-induced cell death of human keratinocytes. As presented in Fig. 1b , pre-incubation of keratinocytes with SNAP at a concentration of 250 lM inhibited the aptitude of TNFa to induce apoptosis by more than 50 %. These results confirm the anti-apoptotic role of both molecules, but do not indicate an interplay between S1P and NO
• . Therefore, we examined whether S1P is able to induce NO
• formation in human keratinocytes. For this purpose, we incubated cells with the cell permeable reagent DAF-2DA, which is able to visualize free NO
• in living cells. Indeed, when keratinocytes were stimulated with S1P an increase of intracellular NO
• formation after treatment with S1P was visible (Fig. 2a) . To further substantiate the formation of NO
• in response to S1P, measurement of the more stable NO
• metabolite NO 2 -in the culture medium by Griess assay was performed. Actually, in Fig. 2b , it is presented that keratinocytes force NO 2 -formation in response to S1P. The effect occurred concentration dependent with a maximum NO 2 -formation at 5 lM of S1P, which is also the most effective dose to prevent keratinocytes from apoptosis.
S1P induces activation of eNOS
The generation of NO
• is catalyzed by the NOS family of proteins. Three distinct isoforms exist, namely nNOS (NOS1), iNOS (NOS2), and eNOS (NOS3) [20] . The expression of these isoforms in the skin has been controversially discussed [18] . Therefore, it was of great interest to evaluate the expression status of the NOS in primary human keratinocytes. Real-time PCR analysis revealed that nNOS and eNOS are constitutively expressed in human keratinocytes, whereas only a weak expression of the iNOS is detectable (Fig. 3a) . But it should be mentioned that UV radiation (80 mJ/cm 2 ) was accompanied by a strong induction of iNOS mRNA (data not shown). Next, we proofed whether S1P influences the mRNA expression of the NOS isoforms. Most interestingly, when cells were stimulated with 5 lM of S1P a drastic increase of eNOS mRNA occurred, whereas levels of nNOS as well as iNOS2 mRNA were unaffected (Fig. 3a) . In detail, a transient increase of eNOS mRNA was detected after treatment with S1P. An enhancement of eNOS in response to S1P became first visible after 3 h and reached maximal levels after 5-12 h (Fig. 3b) . The most effective dose to augment mRNA levels of eNOS was at 5 lM of S1P and resulted in an almost 100-fold increase of the isoenzyme (Fig. 3c) .
Although these results clearly indicate that S1P induces mRNA expression of eNOS, it should be considered that phosphorylation of eNOS is crucial for the activation status of the enzyme. Therefore, phosphorylation of eNOS at Ser 1177 was examined when cells were stimulated with S1P. Most interestingly, S1P induced a transient phosphorylation of eNOS at Ser 1177 . The phosphorylation of eNOS was first visible after 5 min of treatment with S1P and returned to basal levels after 60 min (Fig. 4a) . A maximal phosphorylation occurred 10 min after treatment with S1P. The S1P-mediated eNOS phosphorylation was also dose dependent; the most effective dose to stimulate eNOS activity was 5 lM of S1P, which is similar to the concentration leading to a maximal NO
• formation (Fig. 4b) . These results clearly indicate that S1P induces not only an increase of eNOS mRNA expression but also an activation of the isoenzyme. S1P protects human keratinocytes from apoptosis via formation of NO
•
As S1P induces NO
• via eNOS in human keratinocytes, it was of great interest to examine whether NO
• formation and eNOS activation is involved in the cytoprotective effect of S1P. To address this, we examined the anti-apoptotic effect of S1P in the presence of L-NAME, which inhibits all NOS isoenzymes but with different IC 50 values [37] . Indeed, S1P almost completely lost its ability to protect keratinocytes from TNFa-induced cell death in the presence of L-NAME (Fig. 5a ) indicating a crucial role for NO
• in the S1P-mediated cytoprotection of keratinocytes. To further substantiate that S1P-induced eNOS activation is accountable for the anti-apoptotic effect of the sphingolipid, eNOS was downregulated by the use of siRNA. Measurement of eNOS mRNA expression confirmed a significant downregulation of the isoenzyme after treatment with siRNA (Fig. 5b) . In congruence, S1P lost its ability to generate intracellular NO • in the presence of eNOS siRNA. (Fig. 5c ). Most interestingly, downregulation of eNOS by siRNA almost completely abolished the protective effect of S1P on TNFa-induced apoptosis indicating that NO eNOS is the critical factor for the anti-apoptotic action of S1P in human keratinocytes (Fig. 5d) .
S1P induces NO
• formation and inhibition of apoptosis via the receptor subtype S1P 3 It has been suggested that S1P mediates its anti-apoptotic action, at least in part, via ligation to its G protein-coupled receptors (GPCR) [16] . Therefore, it was of importance to further substantiate whether NO
• formation induced by S1P is mediated through a specific S1P-receptor subtype. As S1P receptors are known to couple to G ai , we measured the NO
• production in response to S1P in the presence of PTX to eliminate functional G ai signalling. Pre-incubation of keratinocytes with PTX significantly diminished the ability of S1P to increase NO 2 -formation (Fig. 6a) . In agreement, S1P lost its ability to activate eNOS, when cells were pretreated with PTX (Fig. 6b) . These results pointed out that eNOS activation and subsequent NO
• formation is mainly dependent on GPCR interacting with G ai proteins. This is in congruence with studies in endothelial cells showing that S1P induces eNOS activation in a PTX-sensitive manner [38] .
Further on, it was of interest to identify the S1P-receptor subtype involved in eNOS activation. For this purpose, the aptitude of specific S1P receptor agonists on NO 2 -formation was examined. As presented in Fig. 6b, FTY720 -phosphate, which is an agonist of all S1P receptors except the S1P 2 receptor subtype, also induced an increase of NO 2 -. A similar action was observed by the use of the S1P 1 /S1P 3 agonist VPC24191, whereas the selective S1P 1 agonist SEW2871 was not able to enhance NO 2 -formation. Taken together, these results suggest that the S1P 3 receptor subtype is the crucial receptor for NO
• formation. It should be mentioned that this is in analogy with studies in endothelial cells identifying the S1P 3 as the exclusive receptor subtype to mediate S1P-induced eNOS activation [39] . To further confirm the involvement of S1P 3 in eNOS activation, siRNA was used to downregulate this receptor subtype. Real-time PCR confirmed a downregulation of S1P 3 mRNA (Fig. 7a) . Indeed, abrogation of the S1P 3 significantly diminished the ability of S1P to induce NO 2 -production (Fig. 7b) . In agreement, eNOS phosphorylation toward S1P was clearly diminished when the S1P 3 receptor subtype was downregulated (Fig. 7c) . Finally, we measured the anti-apoptotic effect of S1P when the S1P 3 receptor was abrogated by siRNA. As presented in Fig. 7c , the ability of S1P to protect keratinocytes from TNFainduced apoptosis was reduced in the absence of the S1P 3 receptor subtype. Taken together, these results indicate that S1P protects human keratinocytes from apoptosis through activation of the S1P 3 receptor subtype via phosphorylation of eNOS and subsequent NO
• formation. Involvement of S1P-receptors in eNOS activation and NO formation. Keratinocytes were pretreated with 200 ng/ml PTX or vehicle for 3 h followed by a stimulation with 5 lM of S1P. For determination of NO 2 -release into the culture medium, the Griess assay was performed after 24 h (a). Human keratinocytes were pretreated with 200 ng/ml PTX for 3 h followed by a stimulation with 5 lM of S1P for 10 min. Then P-eNOS and total eNOS were examined by Western blot analysis. Values are expressed as ratio P-eNOS/eNOS after densitometric analysis (b). Keratinocytes were treated with S1P (5 lM), FTY720-P (1 lM), SEW2871 (1 lM), and VPC24191 (10 lM) for 24 h. Determination of NO 2 -release into the culture medium was performed by the Griess assay (c). All results were confirmed in three independent experiments. *P \ 0.05 and **P \ 0.001 indicate a statistically significant difference versus controls
Discussion
Several studies have pointed out a crucial role for the free radical NO
• and the lipid mediator S1P in skin homeostasis. Here, we present evidence that there exists a cross-communication between both bioactive molecules. Our studies indicate that S1P protects primary human keratinocytes from TNFa-induced apoptosis in an eNOS-dependent NO
• formation via activation of the S1P 3 receptor subtype.
It has been indicated that NO • acts as an autocrine and paracrine molecule in diverse and complex regulatory activities throughout the skin. NO
• synthesis is modulated by the activation of constitutive NOS enzymes, respectively, eNOS and nNOS, as well as by the synthesis of iNOS [40] . It has been indicated that all three NOS isoforms are present in the skin and moreover NO
• can also be generated in the epidermis by bacterial and chemical reduction of sweat nitrate [41] . The calcium-dependent nNOS and eNOS are responsible for the generation of low levels of NO
• while iNOS produces high levels of NO • in a calcium-independent manner. It is not astonishing that NO
• is involved either in maintaining skin homeostasis or in inflammatory and pathological conditions. Thus, vasodilatation, melanogenesis, and protection against environmental challenges are typical NO
• -mediated actions [18, 24, 25, 40] . On the contrary, dysregulation of NO • signalling has been suggested to be involved in hyperproliferative, inflammatory, or immune-mediated skin diseases as well as in skin cancer [42, 43] .
It is of great interest that NO • modulates apoptosis of keratinocytes in a bimodal manner. NO
• either promotes or inhibits apoptosis mostly depending on the NO
• amount and the presence of other radicals [31, 44, 45] . It is well known that UV radiation induces not only apoptosis of keratinocytes but also the formation of NO
• via both constitutive and inducible NOS enzymes. It has been suggested that the activation of constitutive NOS enzymes occurs in the early phase after UV radiation, whereas the elevation of NO
• in the late phase of UV radiation is mediated by iNOS [46] . Thus, the questions remains whether NO
• is contributory or inhibitory on UV-induced apoptosis of keratinocytes. Experiments using eNOS-deficient mice revealed Fig. 7 The S1P 3 -receptor subtype is involved in eNOS activation, NO 2 -release, and the S1P-mediated inhibition of TNFa-induced apoptosis. Keratinocytes were treated with S1P 3 target-specific siRNA or control siRNA for 16 h at a final concentration of 50 nM using the NTER Ó Transfection System. Downregulation of S1P 3 was confirmed by quantitative real-time PCR using Cyclophylin A as reference gene (a). Transfected cells were stimulated with 5 lM of S1P for 24 h followed by the determination of NO 2 -release into the culture medium using the Griess assay (b). Transfected keratinocytes were treated with 5 lM S1P for 10 min followed by the detection of P-eNOS and total eNOS. Then, densitometric analysis of P-eNOS and eNOS was performed. Values are expressed as ratio P-eNOS/eNOS compared to controls (c). Transfected cells were pre-incubated with 5 lM of S1P for 1 h. Then, apoptosis was induced by the incubation with 20 ng/ml TNFa for 16 h. Apoptosis was determined by Annexin V-FITC/PI double staining (d). All results were confirmed in three independent experiments. *P \ 0.05 and **P \ 0.001 indicate a statistically significant difference versus controls the cytoprotective action of eNOS-generated NO
• . Keratinocytes derived from eNOS-deficient mice were markedly more sensitive to UV-induced apoptosis than cells isolated from wild type or iNOS-deficient mice [19] . Furthermore, a cytoprotective role of moderate NO
• levels is not restricted to human keratinocytes. Such a protective role of eNOS has also been detected in a variety of other cell types including endothelial cells, cardiomyocytes, hepatocytes, and lymphoma cells [47] [48] [49] [50] [51] [52] [53] .
Our data indicate that the sphingolipid metabolite S1P protects human keratinocytes from apoptosis via eNOS activation and subsequent production of protective amounts of NO
• . This became obvious as the anti-apoptotic action of S1P in human keratinocytes was completely abolished in the presence of L-NAME, which prevent NO
• formation especially through eNOS inhibition [37] . This result was confirmed by the use of specific siRNA against eNOS. Although the anti-apoptotic effect of S1P has been reported in a variety of cells such as endothelial cells, cardiomyocytes, human hepatocytes, and T-cells, the molecular mechanism is less characterized [54] [55] [56] [57] . It has been suggested that the cytoprotective effect of S1P is a result of an augmented expression of the anti-apoptotic Bcl-2 protein [58] . In accordance, NO
• also protects keratinocytes from UV-induced apoptosis through the induction of Bcl-2 expression [45, 59] .
Most interestingly, an interplay between S1P and eNOS has also been detected in endothelial cells [60] . In congruence to our results, S1P induced an activation of eNOS through phosphorylation at Ser 1177 leading to an increased NO
• formation in these cells. But it should be mentioned that there exist fundamental differences concerning the molecular mechanism of activation. In endothelial cells, Akt activation has been found as the crucial signalling pathway to mediate eNOS phosphorylation [38, 61, 62] . In human keratinocytes, however, S1P inhibits Akt activity indicating that eNOS phosphorylation is mediated by an Akt-independent pathway [63] . Indeed, several alternative signalling routes have been figured out to activate eNOS, such as protein kinase A, AMP-activated kinase, or Ca 2? / calmodulin-dependent kinase-II [34] . In this context, it should be mentioned that S1P has been found to increase intracellular Ca 2? levels indicating an involvement of Ca 2? /calmodulin-dependent eNOS activation [64] . Moreover, in this study, it has been shown that the Ca 2? increase was mainly dependent on S1P 3 activation suggesting a substantial role of this receptor subtype in human keratinocytes [64] . Indeed, our results indicate that eNOS activation as well as cytoprotection in response to S1P is a result of S1P 3 receptor subtype activation. This is in congruence with studies in endothelial cells indicating an involvement of S1P receptors in eNOS activation [38, 61] . Moreover, activation of S1P 3 transduces anti-apoptotic signalling of S1P in endothelial cells and cardiomyocytes [56, 65, 66] . Apart from the exclusive role of the S1P 3 receptor subtype, the involvement of S1P 1 in the protection of human umbilical vein endothelial cells from serumdeprived apoptosis has been described [67] .
There is no doubt that NO • is an important bioactive molecule that mediates a variety of action within the skin. Animal experiments clearly indicate the importance of NO • in prevention of apoptosis and wound healing [19, 68] . Therefore, topical NO
• donors have been discussed as pharmacologic agents to maintain skin homeostasis [69] . Our data indicate that the bioactive lipid mediator S1P mediates its anti-apoptotic action via the activation of eNOS and formation of NO
• . Thus, it would be of interest to further examine the role of the sphingolipid S1P in skin physiology. However, there is also an increasing evidence for a critical role of iNOS and NO
• formation in pathologic processes of the skin like psoriasis and cancer. Indeed, in macrophages it has been indicated that S1P inhibits the expression of iNOS in response to Mycobacterium smegmatis infection [70] . Consequently, further studies should investigate the role of S1P on iNOS expression in the skin. The development of new therapeutic approaches on the basis of sphingolipids would be a remarkable challenge.
